Sun Pharma Advanced Research Company surged for a second straight session after a U.S. court ruled in its favour on the Sezaby Priority Review Voucher. The stock jumped over 11%, extending Tuesday’s 20% rally, even as analysts caution about overbought technicals and continued quarterly losses.
Sun Pharma Advanced Research jumps 11%, extends 2-day rally as US court clears Sezaby PRV
📅 Published: December 3, 2025 |
📂 Category: Uncategorized